<DOC>
	<DOCNO>NCT01987011</DOCNO>
	<brief_summary>The purpose study evaluate immunogenicity safety investigational vaccine subject participation study .</brief_summary>
	<brief_title>Phase III Study Evaluate Immunogenicity Safety MG1109 Healthy Adult Volunteers</brief_title>
	<detailed_description>MG1109 purify , inactivate influenza viral antigen .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Healthy adult available followup study Subjects history exposure H5N1 subtype H5N1 subtype vaccine Subjects immune system disorder include immune deficiency disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Avian influenza</keyword>
</DOC>